A study of 288,111 veterans found that RSV vaccine effectiveness declined significantly within 18 months of administration.
Live Poll
Do you believe it is time to seek a second RSV vaccine dose for added protection?
September 24, 2026
aTyr Pharma Secured FDA Protocol for Efzofitimod TrialThe company received formal agreement from the FDA to begin a Phase 3 study for its drug candidate, efzofitimod.
September 24, 2026
FDA Nominee Pledged Crackdown on Illicit VapesHeidi Overton promised to prioritize enforcement against illegal Chinese nicotine products during her confirmation hearing.
September 24, 2026
Respiratory Vaccine Initiative Has Been LaunchedA new national campaign aims to address vaccine uncertainty and improve public awareness of respiratory illnesses.
September 24, 2026
National Albuterol Shortage Has Been ResolvedThe FDA declared the end of a long-term supply shortage after Ritedose expanded its manufacturing operations.
September 23, 2026
Reynolds American Launched New Vapor Retailer ProgramThe initiative establishes new standards for retail partners selling Vuse Pro Pods to ensure adult-only sales.
September 23, 2026
MSA Safety Showcased New Equipment at NSC EventThe company demonstrated its latest gas detection and protective gear for workplace safety at the 2026 conference.
September 23, 2026
React Health Issued Alert For VOCSN VentilatorsThe company warned that specific ventilator configurations may experience recurring reboots and system alarms.
September 23, 2026
Americans Searched for Respiratory Illness DetailsA new analysis identifies the most frequent health questions asked online as the 2026-27 respiratory season begins.
September 23, 2026
Health Experts Urged Respiratory Virus VaccinationsOfficials recommended immunizations for influenza, COVID-19, RSV, and pneumococcal disease to protect high-risk adults.
September 22, 2026
Researchers Validated AI Model for SBP DiagnosisA machine learning tool demonstrated high negative predictive values for identifying spontaneous bacterial peritonitis.
